SEARCH

SEARCH BY CITATION

References

  • Baba M., Nakajo S., Tu P.-H., Tomita T., Nakaya K., Lee V. M.-Y., Trojanowski J. Q. and Iwatsubo T. (1998) Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am. J. Pathol. 152, 879884.
  • Bennett M. K. and Scheller R. H. (1994) A molecular description of synaptic vesicle membrane trafficking. Annu. Rev. Biochem. 63, 63100.
  • Clayton D. F. and George J. M. (1998) The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci. 21, 249254.
  • Clayton D. F. and George J. M. (1999) Synucleins in synaptic plasticity and neurodegenerative disorders. J. Neurosci. Res. 58, 120129.DOI: 10.1002/(SICI)1097-4547(19991001)58:1<120::AID-JNR12>3.3.CO;2-5
  • Conway K. A., Harper J. D. and Lansbury P. T. (1998) Accelerated invitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson's disease. Nat. Med. 4, 13181320.
  • Conway K. A., Harper J. D. and Lansbury P. T. (2000) Fibrils formed invitro from α-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid. Biochemistry 39, 25522563.
  • Davidson W. S., Jonas A., Clayton D. F. and George J. M. (1998) Stabilization of α-synuclein secondary structure upon binding to synthetic membranes. J. Biol. Chem. 273, 94439449.
  • Engelender S., Kaminsky Z., Guo X., Sharp A. H., Amaravi R. K., Kleiderlein J. J., Margolis R. L., Troncoso J. C., Lanahan A. A., Worley P. F., Dawson V. L., Dawson T. M. and Ross C. A. (1999) Synphilin-1 associates with α-synuclein and promotes the formation of cytosolic inclusions. Nat. Genet. 22, 110114.
  • Forno L. S. (1996) Neuropathology of Parkinson's disease. J. Neuropathol. Exp. Neurol. 55, 259272.
  • Gai W. P., Yuan H. X., Li X. Q., Power J. T. H., Blumbergs P. C. and Jensen P. H. (2000) In situ and in vitro study of colocalization and segregation of α-synuclein, ubiquitin, and lipids in Lewy bodies. Exp. Neurol. 166, 324333.
  • Giasson B. I., Murray I. V. J., Trojanowski J. Q. and Lee V. M.-Y. (2001) A hydrophobic stretch of 12 amino acid residues in the middle of α-synuclein is essential for filament assembly. J. Biol. Chem. 276, 23802386.
  • Goedert M., Spillantini M. G. and Davies S. W. (1998) Filamentous nerve cell inclusions in neurodegenerative diseases. Curr. Opin. Neurobiol. 8, 619632.
  • Hardy J. and Gwinn-Hardy K. (1998) Genetic classification of primary neurodegenerative disease. Science 282, 10751079.
  • Jakes R., Spillantini M. G. and Goedert M. (1994) Identification of two distinct synucleins from human brain. FEBS Lett. 345, 2732.
  • Jenco J. M., Rawlingson A., Daniels B. and Morris A. J. (1998) Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by α- and β-synucleins. Biochemistry 37, 49014909.
  • Jensen P. H., Hager H., Nielsen M. S., Højrup P., Gliemann J. and Jakes R. (1999) α-Synuclein binds to tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356. J. Biol. Chem. 274, 2548125489.
  • Jo E., McLaurin J., Yip C. M., George-Hyslop P. and St. Fraser P. E. (2000) α-Synuclein membrane interactions and lipid specificity. J.Biol. Chem. 275, 3432834334.
  • Jurado L. A., Chockalingam P. S. and Jarrett H. W. (1999) Apocalmodulin. Physiol. Rev. 79, 661682.
  • Kim J. (1997) Evidence that the precursor protein of non-Aβ component of Alzheimer's disease amyloid (NACP) has an extended structure primarily composed of random-coil. Mol. Cells 7, 7883.
  • Krüger R., Kuhn W., Müller T., Woitalla D., Graeber M., Kösel S., Przuntek H., Epplen J. T., Schöls L. and Riess O. (1998) Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nat. Genet. 18, 106108.
  • Lee J.-H., Shin H.-J., Chang C.-S. and Paik S. R. (1998) Comparisons of the NACP self-oligomerizations induced by Αβ25–35 in the presence of dicyclohexylcarbodiimide and N-(ethoxycarbonyl)-2-ethoxy-1,2-dihydroquinoline. Neurochem. Res. 23, 14271434.
  • Leng Y., Chase T. N. and Bennett M. C. (2001) Muscarinic receptor stimulation induces translocation of an α-synuclein oligomer from plasma membrane to a light vesicle fraction in cytoplasm. J. Biol. Chem. 276, 2821228218.
  • Morrissey J. H. (1981) Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity. Anal. Biochem. 105, 307310.
  • Murphy D. D., Rueter S. M., Trojanowski J. Q. and Lee V. M.-Y. (2000) Synucleins are developmentally expressed, and α-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. J. Neurosci. 20, 32143220.
  • Narhi L., Wood S. J., Steavenson S., Jiang Y., Wu G. M., Anafi D., Kaufman S. A., Martin F., Sitney K., Denis P., Louis J.-C., Wypych J., Biere A. L. and Citron M. (1999) Both familial Parkinson's disease mutations accelerate α-synuclein aggregation. J. Biol. Chem. 274, 98439846.
  • Nielsen M. S., Vorum H., Lindersson E. and Jensen P. H. (2001) Ca2+ binding to α-synuclein regulates ligand binding and oligomerization. J. Biol. Chem. 276, 2268022684.
  • O'Neil K. T. and DeGrado W. F. (1990) How calmodulin binds its targets: sequence independent recognitionofamphiphilicα-helices. Trends Biochem. Sci. 15, 5964.
  • O'Neil K. T., Erickson-Viitanen S. and DeGrado W. F. (1989) Photolabeling of calmodulin with basic, amphiphilic α-helical peptides containing p-benzoylphenylalanine. J. Biol. Chem. 264, 1457114578.
  • Ostrerova N., Petrucelli L., Farrer M., Mehta N., Choi P., Hardy J. and Wolozin B. (1999) α-Synuclein shares physical and functional homology with 14–3−3 proteins. J. Neurosci. 19, 57825791.
  • Paik S. R., Lee J.-H., Kim D.-H., Chang C.-S. and Kim J. (1997) Aluminum-induced structural alterations of the precursor of the non-Aβ component of Alzheimer's disease amyloid. Arch. Biochem. Biophys. 344, 325334.
  • Paik S. R., Lee J.-H., Kim D.-H., Chang C.-S. and Kim Y.-S. (1998) Self-oligomerization of NACP, the precursor protein of the non-amyloid β/A4 protein (Aβ) component of Alzheimer's disease amyloid, observed in the presence of a C-terminal Aβ fragment (residues 25–35). FEBS Lett. 421, 7376.
  • Paik S. R., Shin H.-J., Lee J.-H., Chang C.-S. and Kim J. (1999) Copper (II)-induced self-oligomerization of α-synuclein. Biochem. J. 340, 821828.
  • Perrin R. J., Woods W. S., Clayton D. F. and George J. M. (2001) Exposure to long-chain polyunsaturated fatty acids triggers rapid multimerization of synucleins. J. Biol. Chem. 276, 4195841962.
  • Polymeropoulos M. H., Lavedan C., Leroy E., Ide S. E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W. G., Lazzarini A. M., Duvoisin R. C., Iorio G. D., Golbe L. I. and Nussbaum R. L. (1997) Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 276, 20452047.
  • Pronin A. N., Morris A. J., Surguchov A. and Benovic J. L. (2000) Synucleins are a novel class of substrates for G-protein-coupled receptor kinases. J. Biol. Chem. 275, 2651526522.
  • Sanyal G., Richard L. M., Carraway K. L. and Puett D. (1988) Binding of amphiphilic peptides to a carboxy-terminal tryptic fragment of calmodulin. Biochemistry 27, 62296236.
  • Sharon R., Goldberg M. S., Bar-Josef I., Betensky R. A., Shen J. and Selkoe D. J. (2001) α-Synuclein occurs in lipid-rich high molecular weight complexes, binds fatty acids, and shows homology to thefatty acid-binding proteins. Proc. Natl Acad. Sci. USA 98, 91109115.
  • Shibayama-Imazu T., Okahash I., Omata K., Nakajo S., Ochiai H., Nakai Y., Hama T., Nakamura Y. and Nakaya K. (1993) Cell andtissue distribution and developmental change of neuron specific 14 KDa protein (phosphoneuroprotein 14). Brain Res. 622, 1725.
  • Slemmon J. R., Morgan J. I., Fullerton S. M., Danho W., Hilbush B. S. and Wengenack T. M. (1996) Camstatins are peptide antagonists ofcalmodulin based upon a conserved structural motif in PEP-19,neurogranin, and neuromodulin. J. Biol. Chem. 271, 1591115917.
  • Smith P. K., Krohn R. I., Hermanson G. T., Mallia A. K., Gartner F. H., Provenzano M. D., Fujimoto E. K., Goeke N. M., Olson B. J. and Klenk D. C. (1985) Measurement of protein using bicinchoninic acid. Anal. Biochem. 150, 7685.
  • Spillantini M. G., Schmidt M. L., Lee V. M.-Y., Trojanowski J. Q., Jakes R. and Goedert M. (1997) α-Synuclein in Lewy bodies. Nature 388, 839840.
  • Spillantini M. G., Crowther R. A., Jakes R., Hasegawa M. and Goedert M. (1998) α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc. Natl Acad. Sci. USA 95, 64696473.
  • Ueda K., Fukushima H., Masliah E., Xia Y., Iwai A., Yoshimoto M., Otero D. A. C., Kondo J., Ihara Y. and Saitoh T. (1993) Molecularcloning of cDNA encoding an unrecognized component of amyloid in Alzheimer's disease. Proc. Natl Acad. Sci. USA 90, 1128211286.
  • Weinreb P. H., Zhen W., Poon A. W., Conway K. A. and Lansbury P. T. (1996) NACP, a protein implicated in Alzheimer's disease andlearning, is natively unfolded. Biochemistry 35, 1370913715.
  • Yoshimoto M., Iwai A., Kang D., Otero D. A. C., Xia Y. and Saitoh T. (1995) NACP, the precursor protein of the non-amyloid β/A4 protein (Aβ) component of Alzheimer's disease amyloid, binds Aβ and stimulates Aβ aggregation. Proc. Natl Acad. Sci. USA 92, 91419145.
  • Zhang M. and Yuan T. (1998) Molecular mechanisms of calmodulin's functional versatility. Biochem. Cell Biol. 76, 313323.